E2/ERβ Inhibits PPARα to Regulate Cell-Proliferation and Enhance Apoptosis in Hep3B-Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

E2/ERβ Inhibits PPARα to Regulate Cell-Proliferation and Enhance Apoptosis in Hep3B-Hepatocellular Carcinoma

Published:2016-10-18 Issue:3 Volume:23 Page:477-485
ISSN:1219-4956
Container-title:Pathology & Oncology Research
language:en
Short-container-title:Pathol. Oncol. Res.

Author:

Chang-Lee Shu Nu,Hsu Hsi-Hsien,Shibu Marthandam Asokan,Ho Tsung-Jung,Tsai Chih-Hao,Chen Ming-Cheng,Tu Chuan-Chou,Viswanadha Vijaya Padma,Kuo Wei- Wen,Huang Chih-Yang

Funder

Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine,Pathology and Forensic Medicine

Link

http://link.springer.com/article/10.1007/s12253-016-0136-8/fulltext.html

Reference35 articles.

1. Bruix J, Boix L, Sala M, Llovet JM (2004) Focus on hepatocellular carcinoma. Cancer Cell 5(3):215–219

2. Reddy JK, Krishnakantha TP (1975) Hepatic peroxisome proliferation: induction by two novel compounds structurally unrelated to clofibrate. Science 190(4216):787–789

3. Yeldandi AV, Rao MS, Reddy JK (2000) Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis. Mutat Res 448(2):159–177

4. Wu CY, Huang HM, Cho DY (2015) An acute bleeding metastatic spinal tumor from HCC causes an acute onset of cauda equina syndrome. Biomedicine 5(3):18. doi: 10.7603/s40681-015-0018-5

5. Misra P, Reddy JK (2014) Peroxisome proliferator-activated receptor-alpha activation and excess energy burning in hepatocarcinogenesis. Biochimie 98:63–74. doi: 10.1016/j.biochi.2013.11.011

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sensitization of hepatocellular carcinoma cells to HDACi is regulated through hsa-miR-342-5p/CFL1;Cancer Cell International;2024-08-16

2. Exploiting gender-based biomarkers and drug targets: advancing personalized therapeutic strategies in hepatocellular carcinoma;Frontiers in Pharmacology;2024-06-20

3. Estrogen Receptor 1 Inhibition of Wnt/β-Catenin Signaling Contributes to Sex Differences in Hepatocarcinogenesis;Frontiers in Oncology;2021-11-22

4. Therapeutic Value of Estrogen Receptor α in Hepatocellular Carcinoma Based on Molecular Mechanisms;Journal of Clinical and Translational Hepatology;2021-08-10

5. Molecular Initiating Events Associated with Drug-Induced Liver Malignant Tumors: An Integrated Study of the FDA Adverse Event Reporting System and Toxicity Predictions;Biomolecules;2021-06-25